Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

IrelandBack to Ireland

Clinical trials in Dublin – page 21

443 clinical trials in Dublin, Ireland across 14 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Dublin at a glance
443
clinical trials
  • Research sites14
Type of trial
Recruitment status
Quick filters

443 trials in Dublin

Open in trial search

Hereditary angioedema

Not recruiting

Study of Deucrictibant Extended-Release Tablets for Prevention of Hereditary Angioedema Attacks in Adults and Adolescents

Registered drug
Countries:IrelandIreland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Deucrictibant
  • Sponsor:Pharvaris Netherlands B.V.

Asthma

Not recruiting

Study on the Effectiveness and Safety of Benralizumab with Budesonide and Formoterol in Patients with Eosinophilic Asthma Uncontrolled by Standard Treatment

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB

Obesity+1

Not recruiting

Study on Semaglutide for Patients with Obesity and Resistant Hypertension to Improve Blood Pressure Control

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Trinity College Dublin

Non-small cell lung cancer metastatic

Not recruiting

Study of Eftilagimod Alfa with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Immutep

Amyotrophic lateral sclerosis

Not recruiting

Study on the Effects of Triumeq (Abacavir Sulfate, Lamivudine, Dolutegravir Sodium) in Patients with Amyotrophic Lateral Sclerosis (ALS)

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Abacavir Sulfate
  • Sponsor:Stichting TRICALS Foundation

Acute myeloid leukaemia

Not recruiting

Study of gemtuzumab ozogamicin and chemotherapy combinations in children with newly diagnosed acute myeloid leukemia, high-risk myelodysplastic syndrome, or myeloid sarcoma

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:0–17 years
  • Substances:Busulfan
  • Sponsor:The University Of Birmingham

Chronic obstructive pulmonary disease

Not recruiting

Study of tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB

Hormone receptor positive breast cancer

Not recruiting

Study on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Palbociclib
  • Sponsor:ABCSG GmbH

Duchenne muscular dystrophy

Not recruiting

Study on the Effects of Casimersen and Golodirsen for Patients with Duchenne Muscular Dystrophy Amenable to Exon 45 or 53 Skipping

Investigational
Countries:IrelandIreland
  • Participants:0–17 years
  • Substances:Casimersen
  • Sponsor:Sarepta Therapeutics Inc.

Dementia Alzheimer's type

Not recruiting

Study on Lecanemab and Drug Combination for Patients with Early Onset Alzheimer's Disease Due to Genetic Mutation

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:E2814
  • Sponsor:Washington University School Of Medicine

Embolism venous

Not recruiting

Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Embolism venous+1

Not recruiting

Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Other cities in Ireland

The busiest research cities in the country

All 16 cities in Ireland

Clinical research in Dublin

What the registry says about research in the country

01 Oncology Research

Clinical trials investigating innovative treatments for various cancer types, including non-small cell lung cancer, diffuse large B-cell lymphoma, and multiple myeloma. Studies focus on evaluating novel therapeutic combinations and immunotherapy approaches.

  • Metastatic Breast Cancer Treatment
  • Prostate Cancer Therapies
  • Lymphoma Management

Research emphasizes improving patient outcomes through targeted therapies and combination treatments.

02 Infectious Disease Prevention

Studies examining preventive measures against infectious diseases, including HIV prevention and monkeypox vaccination. Research focuses on vaccine efficacy and prophylactic treatments.

  • Pre-exposure Prophylaxis
  • Vaccine Booster Studies
  • Immunogenicity Assessment

Trials aim to enhance protection against emerging infectious diseases through innovative approaches.

03 Chronic Disease Management

Investigations into treatments for chronic conditions, including Sjögren's Disease, Ulcerative Colitis, and Hereditary Angioedema. Studies evaluate both novel therapeutics and existing treatment optimization.

  • Autoimmune Disorders
  • Inflammatory Conditions
  • Metabolic Diseases

Research focuses on improving quality of life and disease management for patients with chronic conditions.

Back to IrelandAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.